DSAM Partners’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-127,588
| Closed | -$6.35M | – | 133 |
|
|
2018
Q2 | $6.35M | Sell |
127,588
-66,662
| -34% | -$3.32M | 1.28% | 22 |
|
|
2018
Q1 | $9.65M | Buy |
194,250
+57,750
| +42% | +$2.87M | 1.64% | 24 |
|
|
2017
Q4 | $5.08M | Buy |
136,500
+62,000
| +83% | +$2.31M | 0.85% | 22 |
|
|
2017
Q3 | $2.35M | Buy |
+74,500
| New | +$2.35M | 0.33% | 45 |
|